“…The emerging IGL-1 solution has shown beneficial outcomes in the preservation of kidney (17,22) and liver (23,24,26,27) and may represent an advance in optimizing pancreatic graft preservation. To the best of our knowledge, the described protocol, which includes 16-hr cold ischemia in a porcine whole PT model that closely resembles clinical PT, is the first study to assess the effectiveness of IGL-1 solution in PT.…”